This study is designed to evaluate the efficacy and safety of the current treatment option and outcome of pediatric lupus nephritis patients in China. Investigators will perform prospective registration study among at least 35 pediatric nephrology medical centers in China.
Study Type
OBSERVATIONAL
Enrollment
1,200
corticosteroid is given to patients orally or methylprednisone is given to patients through i.v.
Hydroxychloroquine is recommended as the basic therapy for lupus nephritis
The typical therapy for cyclophosphamide is either 500 to 750mg/m2 once every month for 6 doses or 8 to 12 mg/kg/d for two consecutive days every two weeks for 6 to 8 doses through i.v.
The Second Xiangya Hospital, Central South University
Changsha, Hunan, China
RECRUITINGComplete remission
complete remission is defined as UPC\<0.2 mg/mg, or 24-hour urine protein\<150mg with normal kidney function and without hematuria
Time frame: 5 years
Partial remission
Partial remission is defined as non-nephrotic range proteinura, decrease of urine protein ≥50%, and serum creatinine remains stable (±25% of baseline) or is improved but not normal yet
Time frame: 5 years
End stage renal disease (ESRD)
ESRD is defined as eGFR\<15ml/1.73m2, initiation of long-term dialysis or kidney
Time frame: 1 year, 2 years, 3 years, 4 years and 5 years
Mortality
Death of patients
Time frame: 1 year, 2 years, 3 years, 4 years and 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The recommended dose of mycophenolate mofetil is 20 to 30mg/kg/d
The recommended dose of azathioprine is 1.5 to 2mg/kg/d
The recommended dose of tacrolimus is 0.05 to 0.15mg/kg/d, Q12h
The recommended initial dose of cyclosporine A is 4 to 6mg/kg/d, Q12h
The recommended dose of rituximab is 375mg/m2 once a week for 2 to 4 doses